Key facts
| Price (PPV) | 319 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | aloglipitine |
| Class | Drugs used in diabetes |
| ATC code | A10BH04 |
| Manufacturer | PROMOPHARM (HIKMA) |
| Presentation | Boite de 28 |
| Hospital price | 212 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement du diabète de type 2 en association à d’autres médicaments hypoglycémiants, dont l’insuline, lorsque ceux-ci, associés à un régime alimentaire et à l’exercice physique, ne permettent pas d’obtenir un contrôle glycémique adéquat.
Find an open pharmacy
On-call pharmacies near you
About Vipidia 25 mg
Vipidia 25 mg belongs to the drugs used in diabetes therapeutic class. In Morocco, this drug is marketed by PROMOPHARM (HIKMA) and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Vipidia 25 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Vipidia 25 mg
Answers to common questions from Moroccan patients about this drug.